Skip to Main Content

Paper Details

Proteogenomics connects somatic mutations to signalling in breast cancer.
Nature
1078
2016
5q, 5q deletion, CDK12, CETN3, EGFR, ERBB2, G-protein-coupled receptor cluster, PAK1, PTK2, RIPK2, SKP1, SRC tyrosine kinase, TLK2, amplicon, amplified regions, basal-like breast cancer, breast cancer, breast cancers, driver genes, mRNA, somatic cancer genome, tyrosine
Author NameAffiliation
Philipp MertinsThe Broad Institute of MIT and Harvard
Deepak ManiThe Broad Institute of MIT and Harvard
Kelly V RugglesNew York University Langone Medical Center
Michael A GilletteThe Broad Institute of MIT and Harvard
Michael A GilletteMassachusetts General Hospital
Karl R ClauserThe Broad Institute of MIT and Harvard
Pei WangIcahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai New York
Xianlong WangFred Hutchinson Cancer Research Center
Jana W QiaoThe Broad Institute of MIT and Harvard
Song CaoMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Song CaoMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Francesca PetraliaIcahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai New York
Emily KawalerNew York University Langone Medical Center
Filip MundtThe Broad Institute of MIT and Harvard
Filip MundtKarolinska Institute
Karsten KrugThe Broad Institute of MIT and Harvard
Zhidong TuIcahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai New York
Jonathan T LeiDan L. Duncan Comprehensive Cancer Center and Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine
Michael L GatzaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Matthew D WilkersonLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Matthew D WilkersonLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Venkata YellapantulaMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Kuan-Lin HuangMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Kuan-Lin HuangMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Chenwei LinFred Hutchinson Cancer Research Center
Chenwei LinFred Hutchinson Cancer Research Center
Michael D McLellanMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Michael D McLellanMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Ping YanFred Hutchinson Cancer Research Center
Sherri R DaviesWashington University School of Medicine
Reid TownsendWashington University School of Medicine
Steven J SkatesMassachusetts General Hospital Cancer Center
Jing WangVanderbilt University School of Medicine
Bing ZhangVanderbilt University School of Medicine
Bing ZhangVanderbilt University School of Medicine
Christopher R KinsingerNational Cancer Institute, National Institutes of Health
Mehdi MesriNational Cancer Institute, National Institutes of Health
Henry RodriguezNational Cancer Institute, National Institutes of Health
Henry RodriguezNational Cancer Institute, National Institutes of Health
Li DingMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Li DingMcDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine
Amanda G PaulovichFred Hutchinson Cancer Research Center
David Feny??New York University Langone Medical Center
David Feny??New York University Langone Medical Center
Matthew J EllisDan L. Duncan Comprehensive Cancer Center and Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine
Steven A CarrThe Broad Institute of MIT and Harvard
Steven A CarrThe Broad Institute of MIT and Harvard
  • 1 - 48

Datasets